ECO Animal Health Group (LON:EAH) Insider David Hallas Purchases 22,346 Shares of Stock

Key Points

  • Insider buying: ECO Animal Health Group insider David Hallas purchased 22,346 shares on July 16 at GBX 89 each, totaling about £19,887.94.
  • Stock moved lower: The shares were down 1.7% and opened at GBX 87, trading below both the 50-day average of GBX 92.59 and the 200-day average of GBX 98.56.
  • Latest financial update: The company recently reported quarterly EPS of GBX 3.26, with a net margin of 2.50% and return on equity of 2.55%.

ECO Animal Health Group plc (LON:EAH - Get Free Report) insider David Hallas bought 22,346 shares of the stock in a transaction dated Thursday, July 16th. The stock was purchased at an average cost of GBX 89 per share, for a total transaction of £19,887.94.

ECO Animal Health Group Trading Down 1.7%

Shares of ECO Animal Health Group stock opened at GBX 87 on Friday. The firm has a market cap of £58.36 million, a price-to-earnings ratio of 19.82 and a beta of 0.00. ECO Animal Health Group plc has a 52-week low of GBX 72 and a 52-week high of GBX 116.90. The company's 50-day simple moving average is GBX 92.59 and its 200-day simple moving average is GBX 98.56. The company has a quick ratio of 2.14, a current ratio of 3.42 and a debt-to-equity ratio of 5.66.

ECO Animal Health Group (LON:EAH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 15th. The company reported GBX 3.26 EPS for the quarter. ECO Animal Health Group had a net margin of 2.50% and a return on equity of 2.55%.

About ECO Animal Health Group

(Get Free Report)




ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Read More

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at ECO Animal Health Group?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ECO Animal Health Group and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles